Kilitch Drugs (India) Investor Sentiment

KILITCH Stock   310.05  3.95  1.29%   
Under 50% of Kilitch Drugs' traders are presently thinking to get in. The analysis of overall sentiment of trading Kilitch Drugs Limited stock suggests that some investors are interested at this time. Kilitch Drugs' investing sentiment shows overall attitude of investors towards Kilitch Drugs Limited.
  
over a year ago at news.google.com         
Kilitch Drugs Standalone September 2023 Net Sales at Rs 31.57 crore, up 40.77 percent Y-o-Y - Moneyc...
Google News at Macroaxis
over a year ago at news.google.com         
Kilitch Healthcare India Limited issues voluntary recall of various ... - Modern Retina
Google News at Macroaxis
over a year ago at news.google.com         
Amazon eye drops recall 7 brands pulled after FDA says products were distributed without approval - ...
Google News at Macroaxis
over a year ago at news.google.com         
Investors Shouldnt Be Too Comfortable With Kilitch Drugs s Earnings - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Kilitch Healthcare recalls eyedrops made for CVS, Walmart Mint - Mint
Google News at Macroaxis
over a year ago at news.google.com         
Tainted Eyedrops Pulled from Walmart, Target, CVS Tied to India ... - Bloomberg
Google News at Macroaxis
over a year ago at news.google.com         
Companies announce their upcoming presentations and data ... - Modern Retina
Google News at Macroaxis
over a year ago at news.google.com         
LSL Pharma Group, Fera Pharmaceuticals announce distribution ... - Ophthalmology Times
Google News at Macroaxis
over a year ago at news.google.com         
Shareholders Would Not Be Objecting To Kilitch Drugs Limiteds CEO Compensation And Heres Why - Simpl...
Google News at Macroaxis
over a year ago at news.google.com         
AstraZeneca Pharma, Tech Mahindra, Canara Bank among 34 stocks that hit 52-week highs 9 touch 52-wee...
Google News at Macroaxis
over a year ago at news.google.com         
Multibagger small-cap stock hits upper circuit on two days in a row after Q4 results Mint - Mint
Google News at Macroaxis
over a year ago at news.google.com         
Kilitch Drugs India Ltd reports consolidated PAT of Rs. 3.56 crores in ... - Equity Bulls
Google News at Macroaxis
over a year ago at news.google.com         
Stock market update Nifty Bank index falls 0.74 percent in a weak market - Economic Times
Google News at Macroaxis
over a year ago at news.google.com         
Stock market update Nifty Realty index falls 0.09 percent in a weak market - Economic Times
Google News at Macroaxis
over a year ago at news.google.com         
Heres Why Kilitch Drugs Has Caught The Eye Of Investors - Simply Wall St
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Kilitch Drugs that are available to investors today. That information is available publicly through Kilitch media outlets and privately through word of mouth or via Kilitch internal channels. However, regardless of the origin, that massive amount of Kilitch data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kilitch Drugs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kilitch Drugs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kilitch Drugs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kilitch Drugs alpha.

Kilitch Drugs Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Pharma stock jumps 14 percent after reporting 7718 percent QoQ increase in net profits - Trade Brains
11/12/2024

Complementary Tools for Kilitch Stock analysis

When running Kilitch Drugs' price analysis, check to measure Kilitch Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kilitch Drugs is operating at the current time. Most of Kilitch Drugs' value examination focuses on studying past and present price action to predict the probability of Kilitch Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kilitch Drugs' price. Additionally, you may evaluate how the addition of Kilitch Drugs to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stocks Directory
Find actively traded stocks across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like